Name: Silence Therapeutics plc (SLN) Balance Sheet
Creator: FinSpry

Silence Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions GBP

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Silence Therapeutics plc (SLN) - Annual data in millions GBP
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Current Assets
Cash and Cash Equivalents	121.33	54.03	66.34	99.25	37.48	13.52	26.49
Short-Term Investments	26.00	0.00	19.76	0.00	13.65	0.00	0.00
Cash & Short-Term Investments	147.33	54.03	86.10	99.25	51.13	13.52	26.49
Accounts Receivable	26.91	18.83	1.11	0.45	45.76	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	13.12	10.39	9.88	5.83	5.38	0.89	0.88
Total Current Assets	187.37	81.02	117.01	116.52	104.31	37.47	29.50
Non-Current Assets
Property, Plant & Equipment (Net)	1.98	1.81	2.66	2.62	1.54	0.61	0.92
Long-Term Investments	0.00	0.00	0.34	0.41	0.41	0.00	0.00
Goodwill	9.39	9.98	9.69	10.25	11.09	0.00	0.00
Intangible Assets	0.31	0.36	0.39	0.03	0.02	0.00	0.00
Other Non-Current Assets	3.59	2.58	0.00	0.00	0.00	0.00	0.00
Total Non-Current Assets	15.27	12.80	13.09	13.31	9.57	8.61	9.39
Total Assets	202.64	93.82	130.10	129.83	117.38	46.08	38.89
Current Liabilities
Accounts Payable	3.70	17.59	3.86	5.49	3.12	0.00	0.00
Short-Term Debt	0.12	0.00	0.00	0.00	0.00	0.00	0.00
Accrued Liabilities	8.36	11.72	10.15	8.39	8.06	0.00	0.00
Deferred Revenue	0.31	6.57	10.73	5.73	23.27	0.00	0.00
Other Current Liabilities	11.81	0.00	0.00	0.00	0.00	0.00	0.00
Total Current Liabilities	16.82	17.77	26.56	20.47	34.92	9.65	3.83
Non-Current Liabilities
Long-Term Debt	0.00	59.00	63.75	0.00	51.34	0.00	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	51.79	59.00	76.83	97.85	51.34	15.52	0.00
Total Liabilities	68.61	76.77	103.38	118.32	105.01	25.17	3.83
Stockholders' Equity
Common Stock	10.29	8.85	6.52	6.06	5.69	0.00	0.00
Retained Earnings	-474.04	-442.62	-318.60	-300.92	-251.51	-152.00	-133.78
Accumulated Other Comprehensive Income	-11.78	11.11	29.45	32.11	48.30	0.00	0.00
Additional Paid-in Capital	609.56	455.77	280.60	255.79	158.93	143.34	0.00
Shares Outstanding	141.67	118.85	107.81	89.78	0.00	0.00	0.00
Total Stockholders' Equity	134.02	17.05	26.71	11.51	12.37	20.91	35.06
Total Liabilities & Equity	202.64	93.82	130.10	129.83	85.97	46.08	38.89